May Hill Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.12M Buy
1,832
+74
+4% +$87.3K 0.42% 46
2026
Q2
$2.11M Buy
1,758
+269
+18% +$275K 0.44% 50
2026
Q1
$1.37M Sell
1,489
-96
-6% -$97.3K 0.34% 56
2025
Q4
$1.7M Buy
1,585
+216
+16% +$207K 0.46% 44
2025
Q3
$1.04M Buy
1,369
+108
+9% +$80.4K 0.31% 55
2025
Q2
$983K Sell
1,261
-321
-20% -$249K 0.32% 56
2025
Q1
$1.31M Buy
1,582
+21
+1% +$17.5K 0.49% 37
2024
Q4
$1.21M Buy
+1,561
New +$1.29M 0.47% 40

Other funds holding LLY

May Hill Capital's LLY Position: Q3 2026 in Review

May Hill Capital increased its Eli Lilly (LLY) stake by 4.2% in Q3 2026, buying an estimated $87.3K and bringing the position to 1,832 shares worth $2.12M. The position accounts for 0.42% of the portfolio, ranked #46.

May Hill Capital first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • May Hill Capital held 1,832 shares of Eli Lilly worth $2.12M as of Q3 2026.
  • May Hill Capital bought 74 Eli Lilly shares in Q3 2026, an estimated $87.3K.
  • Eli Lilly made up 0.42% of May Hill Capital's portfolio in Q3 2026, its #46 holding.
  • May Hill Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.